STOCK TITAN

Nutex Health (NASDAQ: NUTX) extends HaloMD dispute pact to 2029

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Nutex Health Inc. entered into a First Amendment to its Payment Dispute Resolution Services Agreement with HaloMD, L.L.C., effective June 30, 2026. The amendment shifts fees to a pay-on-collected basis retroactive to the original May 1, 2024 agreement, adjusts the service fee structure for federal and state net settlement amounts obtained on or after July 1, 2026, and allows HaloMD access to remittance data to confirm payment of awarded claims.

The company also gains the right to handle dispute resolution services in-house or through another vendor for certain future hospital facilities, and the agreement’s initial term is extended through December 31, 2029, with automatic one-year renewals. Separately, CMS and other federal agencies cut the Federal IDR non-refundable administrative fee from $115 to $15 per party per dispute, effective June 11, 2026. Nutex Health expects these changes to reduce overall arbitration-related costs.

Positive

  • None.

Negative

  • None.
Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Federal IDR administrative fee (old) $115 per party per dispute Non-refundable fee before June 11, 2026
Federal IDR administrative fee (new) $15 per party per dispute Non-refundable fee effective June 11, 2026
Agreement amendment effective date June 30, 2026 Effective date of First Amendment with HaloMD
Original agreement date May 1, 2024 Date of original Payment Dispute Resolution Services Agreement
Adjusted settlements start date July 1, 2026 Net settlement amounts subject to amended fee structure
Agreement term end December 31, 2029 End of extended initial term, before automatic renewals
No Surprises Act regulatory
"The services provided under the Agreement are subject to the regulatory framework established by the No Surprises Act"
A federal law that protects patients from unexpected out-of-network medical bills by limiting what providers and insurers can charge when care is received without a clear cost agreement. For investors, it changes how hospitals, physician groups, insurers and medical billing firms set prices, collect revenue and resolve payment disputes—similar to changing the rules of a game, it can shift revenue streams, margins and legal risk across the healthcare sector.
Federal Independent Dispute Resolution (IDR) process regulatory
"as implemented through the Federal Independent Dispute Resolution (IDR) process"
non-refundable administrative fee financial
"reduced the non-refundable administrative fee for the Federal IDR process from $115 to $15"
pay-on-collected basis financial
"transitions the fee payment structure to a pay-on-collected basis as opposed to payment due on award determination"
automatic one-year renewals regulatory
"extends the initial term of the Agreement through December 31, 2029, subject to automatic one-year renewals"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What agreement did Nutex Health (NUTX) amend with HaloMD?

Nutex Health amended its Payment Dispute Resolution Services Agreement with HaloMD, originally dated May 1, 2024. The First Amendment revises fee timing, fee structures, procedures, term length, and Nutex’s flexibility to use in-house or alternative vendors for certain future hospital facilities.

How does the Nutex Health (NUTX) and HaloMD amendment change fee payments?

The amendment moves to a pay-on-collected fee structure instead of payment due on award determination. This change applies retroactively to the original agreement’s effective date, aligning HaloMD’s compensation more closely with actual collections from resolved disputes.

What is the new term of Nutex Health’s (NUTX) HaloMD agreement?

The amendment extends the agreement’s initial term through December 31, 2029, with automatic one-year renewals thereafter. This creates a multi-year framework for dispute resolution services supporting Nutex Health’s operations under the No Surprises Act and related processes.

How did CMS’s IDR fee change impact Nutex Health (NUTX)?

CMS and federal agencies reduced the Federal IDR non-refundable administrative fee from $115 to $15 per party per dispute, effective June 11, 2026. Nutex Health states that, together with the HaloMD amendment, this is expected to lower its arbitration-related costs.

What flexibility does Nutex Health (NUTX) gain from the HaloMD amendment?

Nutex Health gains the right to perform dispute resolution services in-house or via another third-party vendor for certain future hospital facilities. This flexibility may influence how the company manages claims under the Federal Independent Dispute Resolution process.
0001479681FALSE00014796812026-07-152026-07-15

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
  
Date of Report (Date of earliest event reported): July 15, 2026
  
NUTEX HEALTH INC.
(Exact name of registrant as specified in its charter)
  
Delaware 
001-41346
11-3363609 
(State or Other Jurisdiction 
of Incorporation) 
(Commission File Number) 
(I.R.S. Employer 
Identification No.) 
  
1776 Yorktown Street, Suite 700, Houston, Texas 77056
(Address of principal executive offices) (zip code)
  
(713) 660-0557
(Registrant’s telephone number, including area code) 
  
N/A 
(Former name or former address, if changed since last report) 
  
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 
  
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 
Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 
  
Securities registered pursuant to Section 12(b) of the Act: 
  
Title of each class 
  
Trading Symbol(s) 
  
Name of each exchange on which registered 
Common Stock, $0.001 par value 
  
NUTX 
  
The NASDAQ Stock Market LLC 
  
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). 
Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.




Item 1.01 Entry into a Material Definitive Agreement.
Effective June 30, 2026, Nutex Health Inc., a Delaware corporation (the “Company”), on July 15, 2026, entered into a First Amendment (the “Amendment”) to that certain Payment Dispute Resolution Services Agreement, dated as of May 1, 2024 (the “Agreement”), by and between the Company and HaloMD, L.L.C., a Delaware limited liability company (“HaloMD”).
The services provided under the Agreement are subject to the regulatory framework established by the No Surprises Act, as implemented through the Federal Independent Dispute Resolution (IDR) process.
The Amendment, among other things, (i) transitions the fee payment structure to a pay-on-collected basis as opposed to payment due on award determination, retroactive to the Effective Date of the original Agreement, (ii) amends the service fee structure applicable to various federal and state net settlement amounts obtained on or after July 1, 2026, (iii) makes procedural amendments such as allowing HaloMD access to remittance data to confirm payment of awarded claims, (iv) provides the Company the right to perform dispute resolution services either in-house or through the engagement of another third-party vendor or service provider with respect to certain future hospital facilities, and (v) extends the initial term of the Agreement through December 31, 2029, subject to automatic one-year renewals.
On June 4, 2026, CMS and federal agencies reduced the non-refundable administrative fee for the Federal IDR process from $115 to $15 per party per dispute. This reduction took effect on June 11, 2026, to lower financial barriers for healthcare providers and payers.
As a result of the Amendment and the recently adopted new CMS Rules, the Company expects a reduction in our overall arbitration related costs.




 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
 
Date: July 21, 2026
NUTEX HEALTH INC. 
  
  
  
By: 
/s/ Jon C. Bates 
  
  
Jon C. Bates 
Chief Financial Officer 
  
  
 


Filing Exhibits & Attachments

3 documents